232 related articles for article (PubMed ID: 38232702)
21. Advances in Acute Myeloid Leukemia Genomics, Where Do We Stand in 2018?
Madanat YF; Kalaycio ME; Nazha A
Acta Med Acad; 2019 Apr; 48(1):35-44. PubMed ID: 31264431
[TBL] [Abstract][Full Text] [Related]
22. Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia.
Koschade SE; Klann K; Shaid S; Vick B; Stratmann JA; Thölken M; Meyer LM; Nguyen TD; Campe J; Moser LM; Hock S; Baker F; Meyer CT; Wempe F; Serve H; Ullrich E; Jeremias I; Münch C; Brandts CH
Leukemia; 2022 Oct; 36(10):2396-2407. PubMed ID: 35999260
[TBL] [Abstract][Full Text] [Related]
23. Lipids and the cancer stemness regulatory system in acute myeloid leukemia.
Lim INX; Nagree MS; Xie SZ
Essays Biochem; 2022 Sep; 66(4):333-344. PubMed ID: 35996953
[TBL] [Abstract][Full Text] [Related]
24. Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia.
Mumme HL; Raikar SS; Bhasin SS; Thomas BE; Lawrence T; Weinzierl EP; Pang Y; DeRyckere D; Gawad C; Wechsler DS; Porter CC; Castellino SM; Graham DK; Bhasin M
Genome Med; 2023 Oct; 15(1):83. PubMed ID: 37845689
[TBL] [Abstract][Full Text] [Related]
25. Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification.
Fu S; Liu X; Luo M; Xie K; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2017 Apr; 14(4):351-362. PubMed ID: 28276747
[TBL] [Abstract][Full Text] [Related]
26. Freezing effects on the acute myeloid leukemia cell proteome and phosphoproteome revealed using optimal quantitative workflows.
Aasebø E; Mjaavatten O; Vaudel M; Farag Y; Selheim F; Berven F; Bruserud Ø; Hernandez-Valladares M
J Proteomics; 2016 Aug; 145():214-225. PubMed ID: 27107777
[TBL] [Abstract][Full Text] [Related]
27. Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations.
Simonetti G; Mengucci C; Padella A; Fonzi E; Picone G; Delpino C; Nanni J; De Tommaso R; Franchini E; Papayannidis C; Marconi G; Pazzaglia M; Perricone M; Scarpi E; Fontana MC; Bruno S; Tebaldi M; Ferrari A; Bochicchio MT; Ghelli Luserna Di Rorà A; Ghetti M; Napolitano R; Astolfi A; Baldazzi C; Guadagnuolo V; Ottaviani E; Iacobucci I; Cavo M; Castellani G; Haferlach T; Remondini D; Capozzi F; Martinelli G
Leukemia; 2021 Oct; 35(10):2813-2826. PubMed ID: 34193978
[TBL] [Abstract][Full Text] [Related]
28. Pan-cancer proteogenomics characterization of tumor immunity.
Petralia F; Ma W; Yaron TM; Caruso FP; Tignor N; Wang JM; Charytonowicz D; Johnson JL; Huntsman EM; Marino GB; Calinawan A; Evangelista JE; Selvan ME; Chowdhury S; Rykunov D; Krek A; Song X; Turhan B; Christianson KE; Lewis DA; Deng EZ; Clarke DJB; Whiteaker JR; Kennedy JJ; Zhao L; Segura RL; Batra H; Raso MG; Parra ER; Soundararajan R; Tang X; Li Y; Yi X; Satpathy S; Wang Y; Wiznerowicz M; González-Robles TJ; Iavarone A; Gosline SJC; Reva B; Robles AI; Nesvizhskii AI; Mani DR; Gillette MA; Klein RJ; Cieslik M; Zhang B; Paulovich AG; Sebra R; Gümüş ZH; Hostetter G; Fenyö D; Omenn GS; Cantley LC; Ma'ayan A; Lazar AJ; Ceccarelli M; Wang P;
Cell; 2024 Feb; 187(5):1255-1277.e27. PubMed ID: 38359819
[TBL] [Abstract][Full Text] [Related]
29. Proteogenomics refines the molecular classification of chronic lymphocytic leukemia.
Herbst SA; Vesterlund M; Helmboldt AJ; Jafari R; Siavelis I; Stahl M; Schitter EC; Liebers N; Brinkmann BJ; Czernilofsky F; Roider T; Bruch PM; Iskar M; Kittai A; Huang Y; Lu J; Richter S; Mermelekas G; Umer HM; Knoll M; Kolb C; Lenze A; Cao X; Österholm C; Wahnschaffe L; Herling C; Scheinost S; Ganzinger M; Mansouri L; Kriegsmann K; Kriegsmann M; Anders S; Zapatka M; Del Poeta G; Zucchetto A; Bomben R; Gattei V; Dreger P; Woyach J; Herling M; Müller-Tidow C; Rosenquist R; Stilgenbauer S; Zenz T; Huber W; Tausch E; Lehtiö J; Dietrich S
Nat Commun; 2022 Oct; 13(1):6226. PubMed ID: 36266272
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory response mediates cross-talk with immune function and reveals clinical features in acute myeloid leukemia.
Zhong FM; Yao FY; Liu J; Zhang HB; Li MY; Jiang JY; Xu YM; Yang WM; Li SQ; Zhang J; Cheng Y; Xu S; Huang B; Wang XZ
Biosci Rep; 2022 May; 42(5):. PubMed ID: 35441668
[TBL] [Abstract][Full Text] [Related]
31. The Evolving AML Genomic Landscape: Therapeutic Implications.
Horibata S; Alyateem G; DeStefano CB; Gottesman MM
Curr Cancer Drug Targets; 2020; 20(7):532-544. PubMed ID: 32329691
[TBL] [Abstract][Full Text] [Related]
32. [Stratified treatment of fit and unfit acute myeloid leukemia].
Yoshimoto G
Rinsho Ketsueki; 2021; 62(8):967-977. PubMed ID: 34497237
[TBL] [Abstract][Full Text] [Related]
33. Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis.
Dillon LW; Ghannam J; Nosiri C; Gui G; Goswami M; Calvo KR; Lindblad KE; Oetjen KA; Wilkerson MD; Soltis AR; Sukumar G; Dalgard CL; Thompson J; Valdez J; DeStefano CB; Lai C; Sciambi A; Durruthy-Durruthy R; Llanso A; Gulati S; Wang S; Ooi A; Dagur PK; McCoy JP; Burr P; Li Y; Hourigan CS
Blood Cancer Discov; 2021 Jul; 2(4):319-325. PubMed ID: 34258102
[TBL] [Abstract][Full Text] [Related]
34. Genomics-based Approach and Prognostic Stratification Significance of Gene Mutations in Intermediate-risk Acute Myeloid Leukemia.
Wang BH; Li YH; Yu L
Chin Med J (Engl); 2015 Sep; 128(17):2395-403. PubMed ID: 26315090
[TBL] [Abstract][Full Text] [Related]
35. Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies.
Hou HA; Tien HF
J Biomed Sci; 2020 Jul; 27(1):81. PubMed ID: 32690020
[TBL] [Abstract][Full Text] [Related]
36. Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery.
Simonetti G; Padella A; do Valle IF; Fontana MC; Fonzi E; Bruno S; Baldazzi C; Guadagnuolo V; Manfrini M; Ferrari A; Paolini S; Papayannidis C; Marconi G; Franchini E; Zuffa E; Laginestra MA; Zanotti F; Astolfi A; Iacobucci I; Bernardi S; Sazzini M; Ficarra E; Hernandez JM; Vandenberghe P; Cools J; Bullinger L; Ottaviani E; Testoni N; Cavo M; Haferlach T; Castellani G; Remondini D; Martinelli G
Cancer; 2019 Mar; 125(5):712-725. PubMed ID: 30480765
[TBL] [Abstract][Full Text] [Related]
37. Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology.
Ji S; Feng L; Fu Z; Wu G; Wu Y; Lin Y; Lu D; Song Y; Cui P; Yang Z; Sang C; Song G; Cai S; Li Y; Lin H; Zhang S; Wang X; Qiu S; Zhang X; Hua G; Li J; Zhou J; Dai Z; Wang X; Ding L; Wang P; Gao D; Zhang B; Rodriguez H; Fan J; Clevers H; Zhou H; Sun Y; Gao Q
Sci Transl Med; 2023 Jul; 15(706):eadg3358. PubMed ID: 37494474
[TBL] [Abstract][Full Text] [Related]
38. The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives.
Hernandez-Valladares M; Bruserud Ø; Selheim F
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957646
[TBL] [Abstract][Full Text] [Related]
39. Foretinib Is Effective in Acute Myeloid Leukemia by Inhibiting FLT3 and Overcoming Secondary Mutations That Drive Resistance to Quizartinib and Gilteritinib.
Wang P; Zhang Y; Xiang R; Yang J; Xu Y; Deng T; Zhou W; Wang C; Xiao X; Wang S
Cancer Res; 2024 Mar; 84(6):905-918. PubMed ID: 38231480
[TBL] [Abstract][Full Text] [Related]
40. Functional genomic landscape of acute myeloid leukaemia.
Tyner JW; Tognon CE; Bottomly D; Wilmot B; Kurtz SE; Savage SL; Long N; Schultz AR; Traer E; Abel M; Agarwal A; Blucher A; Borate U; Bryant J; Burke R; Carlos A; Carpenter R; Carroll J; Chang BH; Coblentz C; d'Almeida A; Cook R; Danilov A; Dao KT; Degnin M; Devine D; Dibb J; Edwards DK; Eide CA; English I; Glover J; Henson R; Ho H; Jemal A; Johnson K; Johnson R; Junio B; Kaempf A; Leonard J; Lin C; Liu SQ; Lo P; Loriaux MM; Luty S; Macey T; MacManiman J; Martinez J; Mori M; Nelson D; Nichols C; Peters J; Ramsdill J; Rofelty A; Schuff R; Searles R; Segerdell E; Smith RL; Spurgeon SE; Sweeney T; Thapa A; Visser C; Wagner J; Watanabe-Smith K; Werth K; Wolf J; White L; Yates A; Zhang H; Cogle CR; Collins RH; Connolly DC; Deininger MW; Drusbosky L; Hourigan CS; Jordan CT; Kropf P; Lin TL; Martinez ME; Medeiros BC; Pallapati RR; Pollyea DA; Swords RT; Watts JM; Weir SJ; Wiest DL; Winters RM; McWeeney SK; Druker BJ
Nature; 2018 Oct; 562(7728):526-531. PubMed ID: 30333627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
